TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials

Authors: Khalil Choucair, Susan Morand, Laura Stanbery, Gerald M. Edelman, Lance D. Dworkin, John Nemunaitis - Cancer Gene Therapy 2020 cited by 169